• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于管理新冠肺炎的吸入式水凝胶微球:一种新型清扫者生物平台。

Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform.

作者信息

Cheng Ruoyu, Santos Hélder A

机构信息

Department of Biomedical Engineering and W.J. Kolff Institute for Biomedical Engineering and Materials Science, University of Groningen/University Medical Center Groningen, Ant. Deusinglaan 1, 9713 AV Groningen, the Netherlands.

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland.

出版信息

Matter. 2022 Apr 6;5(4):1065-1067. doi: 10.1016/j.matt.2022.03.008.

DOI:10.1016/j.matt.2022.03.008
PMID:35402896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8985243/
Abstract

The cytokine storm caused by SARS-CoV-2 infection threatens the condition of patients, even leading to death. In a recent issue of , Prof. Wenguo Cui and co-workers have prepared lung-sweeper inhaled hydrogel microspheres for intratracheal neutralization of COVID-19 and cytokine storm calming, which could be applied for antiviral tissue regeneration, drug delivery, and disease diagnosis.

摘要

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染引起的细胞因子风暴威胁着患者的病情,甚至导致死亡。在最近一期的《 》中,翁国翠教授及其同事制备了肺清扫吸入水凝胶微球,用于气管内中和2019冠状病毒病(COVID-19)并平息细胞因子风暴,可应用于抗病毒组织再生、药物递送和疾病诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58a3/8985243/e8cebd0062b2/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58a3/8985243/e8cebd0062b2/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58a3/8985243/e8cebd0062b2/gr1_lrg.jpg

相似文献

1
Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform.用于管理新冠肺炎的吸入式水凝胶微球:一种新型清扫者生物平台。
Matter. 2022 Apr 6;5(4):1065-1067. doi: 10.1016/j.matt.2022.03.008.
2
Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm.用于气管内中和新冠病毒并平息细胞因子风暴的吸入式工程化血管紧张素转换酶2微流体微球
Matter. 2022 Jan 5;5(1):336-362. doi: 10.1016/j.matt.2021.09.022. Epub 2021 Oct 19.
3
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者:一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
4
Erratum: Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm.勘误:用于气管内中和新冠病毒及平息细胞因子风暴的吸入式工程化血管紧张素转换酶2微流控微球。
Matter. 2023 Jun 7;6(6):2094. doi: 10.1016/j.matt.2023.04.021.
5
A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.基于网络的分析揭示了维生素 D 抑制 SARS-CoV-2 感染中细胞因子风暴和病毒的机制。
Front Immunol. 2020 Dec 9;11:590459. doi: 10.3389/fimmu.2020.590459. eCollection 2020.
6
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.环孢素 A 通过三种 SARS-CoV-2 变体抑制肺细胞中的病毒感染和释放以及细胞因子产生。
Microbiol Spectr. 2022 Feb 23;10(1):e0150421. doi: 10.1128/spectrum.01504-21. Epub 2022 Jan 5.
7
Cytokine storm induced by SARS-CoV-2.由 SARS-CoV-2 引起的细胞因子风暴。
Clin Chim Acta. 2020 Oct;509:280-287. doi: 10.1016/j.cca.2020.06.017. Epub 2020 Jun 10.
8
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death.治疗靶点:SARS-CoV-2 感染诱导的细胞死亡。
Front Immunol. 2022 May 17;13:870216. doi: 10.3389/fimmu.2022.870216. eCollection 2022.
9
Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.针对 SARS-CoV-2 生命周期和 COVID-19 细胞因子风暴的天然产物靶向药物发现。
Am J Chin Med. 2022;50(4):927-959. doi: 10.1142/S0192415X22500380.
10
Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.新冠病毒肺炎患者细胞因子风暴及细胞因子靶向治疗的危害:综述
J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193.

引用本文的文献

1
Peptide Nucleic Acid Clamp-Assisted Photothermal Multiplexed Digital PCR for Identifying SARS-CoV-2 Variants of Concern.肽核酸夹辅助光热多重数字 PCR 用于鉴定关注的 SARS-CoV-2 变体。
Adv Sci (Weinh). 2024 Apr;11(13):e2306088. doi: 10.1002/advs.202306088. Epub 2024 Jan 19.

本文引用的文献

1
Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands.在荷兰养殖水貂及其相关人群中 SARS-CoV-2 的适应、传播和传播。
Nat Commun. 2021 Nov 23;12(1):6802. doi: 10.1038/s41467-021-27096-9.
2
ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.ACE2 样羧肽酶 B38-CAP 可预防 SARS-CoV-2 诱导的肺损伤。
Nat Commun. 2021 Nov 23;12(1):6791. doi: 10.1038/s41467-021-27097-8.
3
Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series.
康復期血漿治療對印尼 8 例非插管 COVID-19 患者的療效:病例系列研究。
J Med Case Rep. 2021 Nov 23;15(1):564. doi: 10.1186/s13256-021-03059-y.
4
Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm.用于气管内中和新冠病毒并平息细胞因子风暴的吸入式工程化血管紧张素转换酶2微流体微球
Matter. 2022 Jan 5;5(1):336-362. doi: 10.1016/j.matt.2021.09.022. Epub 2021 Oct 19.
5
Antiviral adsorption activity of porous silicon nanoparticles against different pathogenic human viruses.多孔硅纳米颗粒对不同致病性人类病毒的抗病毒吸附活性
Bioact Mater. 2022 Jan;7:39-46. doi: 10.1016/j.bioactmat.2021.06.001. Epub 2021 Jun 16.
6
Clinical characterization of respiratory large droplet production during common airway procedures using high-speed imaging.利用高速成像技术对常见气道操作过程中呼吸大液滴产生的临床特征进行描述。
Sci Rep. 2021 May 20;11(1):10627. doi: 10.1038/s41598-021-89760-w.
7
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.SARS-CoV-2 中和抗体 LY-CoV555 治疗门诊新冠患者的疗效。
N Engl J Med. 2021 Jan 21;384(3):229-237. doi: 10.1056/NEJMoa2029849. Epub 2020 Oct 28.
8
Biomedical nanoparticle design: What we can learn from viruses.生物医学纳米颗粒设计:我们能从病毒中学到什么。
J Control Release. 2021 Jan 10;329:552-569. doi: 10.1016/j.jconrel.2020.09.045. Epub 2020 Sep 30.
9
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.来自 COVID-19 患者的强效中和抗体定义了多个易损目标。
Science. 2020 Aug 7;369(6504):643-650. doi: 10.1126/science.abc5902. Epub 2020 Jun 15.